C3 and bacterial infectious disease: Thus, hyperglycemic conditions dramatically alter the interaction of C3 and pathogenic bacteria in surprising ways that provide new insight into hyperglycemia-mediated immunocompromise contributing to bacterial infections in diabetic patients.